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ABSTRACT:  
 
Objectives:  The current study investigated whether associations between pain and the additional 
symptoms associated with fibromyalgia are different in persons with chronic widespread (CWP) 
compared to multi-site pain (MSP), with or without joint areas. 
 
Patients/Methods:  Six studies were utilized: 1958 British birth cohort, EpiFunD, Kid LBP, MUSICIAN, 
SHAMA and WHEST (females) studies.  MSP was defined as the presence of pain in ≥8/≥10 body sites 
(adults/children) indicated on 4-view body manikins; conducted firstly to include joints (+joints) and 
secondly without (-joints).   
 
The relationship between pain and fatigue, sleep disturbance, somatic symptoms and mood 
impairment, were assessed using logistic regression.  Results are presented as odds ratios (OR), with 
95% confidence intervals (CI). 
 
Results:  There were 34,818 participants across the study populations (adults: mean age range 42-
56yrs, % male 43-51 (excluding WHEST), CWP prevalence 12-17%).  Amongst those reporting MSP, 
the proportion reporting CWP ranged between 62-76%. 
 
Amongst those reporting the symptoms associated with fibromyalgia, there was an increased 
likelihood of reporting pain, the magnitude of which were similar regardless of definition used.  For 
example, within WHEST; reporting moderate/severe fatigue (Chalder fatigue scale 4-11) was 
associated with over a 5-fold increase in likelihood of reporting pain [CWP OR 5.2, 95%CI 3.9-6.9; 
MSP+joints 6.5, 5.0-8.6; MSP-joints 6.5, 4.7-9.0].  
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Discussion:  This large-scale study demonstrates that, regardless of pain definition used, the 
magnitude of association between pain and other associated symptoms of fibromyalgia are similar.  
This supports the continued collection of both when classifying fibromyalgia but highlights that pain 
may not require to follow the definition outlined within the 1990ACR criteria. 
 
Significance and Innovations –  
 
• We have developed a description of multi-site pain which gives a similar prevalence to 
chronic widespread – defined as the presence of ≥8 pain sites,  
• The magnitude of association between pain and the symptoms associated with fibromyalgia 
are similar regardless if joint areas were included in the definition of multisite pain or not,  
• The continued collection of information on both pain and associated symptoms when 
classifying fibromyalgia remains important, however the definition of pain may not 
necessarily require to follow those outlined by the 1990 ACR criteria for fibromyalgia. 
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INTRODUCTION 
 
The understanding and classification of pain syndromes, such as fibromyalgia, have been evolving.  
Since its early beginnings, as fibrositis, interest in fibromyalgia has steadily increased especially with 
regard to strategies used for the classification of affected individuals, which remain controversial.  
 
The initial, American College of Rheumatology (ACR) endorsed, 1990 classification criteria for 
fibromyalgia required the presence of contralateral (left side, right side, above waist and below 
waist) and axial body pain in addition to pain on palpation in at least 11 (of 18) specified anatomical 
points [1].  Although these criteria resulted in many clinical and epidemiological studies, which 
improved the understanding of the aetiology and outcome of fibromyalgia, there were issues with 
operationalisation in the clinical setting, partly due to the inconsistency in examination for tender 
points [2].  These pain-centred criteria also failed to consider other common, non-pain, fibromyalgia 
symptoms such as fatigue.  Generally, the agreement between the ACR 1990 classification criteria 
and clinical fibromyalgia diagnosis is around 75% [3].  
 
In response to these limitations, the proposed 2010 preliminary diagnostic criteria (and the 2011 
modification for research) moved fibromyalgia from a pain-focussed, to a symptom-focussed 
condition [4, 5].  In doing so, the pain aspect of the criteria moved from requiring this to be 
‘widespread’, to being ‘multi-site’ and the previously required tender point examination was 
removed.  In addition to the presence of chronic multi-site pain (lasting ≥3 months), the proposed 
diagnostic criteria also required the presence of additional symptoms associated with fibromyalgia; 
fatigue, waking unrefreshed, somatic and cognitive symptoms.  The 2010 diagnostic criteria have 
provoked considerable debate, have been criticized as being difficult to operationalise [6], and 
alternative criteria have also been proposed [7].  It is also important to note that all three proposed 
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criteria for fibromyalgia (1990, preliminary 2010 and 2011 modification) were developed in 
populations of rheumatic disease patients. 
 
In this context the current analysis was undertaken, as part of the ACTTION initiative (Analgesic, 
Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks): 
developing a new taxonomy for pain conditions.  Specifically informing the development of a 
taxonomy for fibromyalgia, the aims of the current analysis were to a) assess and compare the 
descriptive epidemiology of pain reporting in the general population, using ‘widespread’ and ‘multi-
site’ pain definitions (with and without the inclusion of joints), b) assess the relationship between 
these pain definitions and the other associated symptoms of fibromyalgia, and due to the 
predominance of fibromyalgia in females, c) determine whether there is any sexual dimorphism in 
the reporting of these symptoms. 
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PATIENTS AND METHODS 
 
Study populations: 
Six existing studies (five with general population and one with school-based sampling frame), were 
used for the current post-hoc analysis.  In all studies participants were asked if they had 
experienced, during the previous month, aches or pains lasting for at least one day.  Positive 
responders were consequently invited to mark the specific areas in which this pain had occurred on 
four-view blank body manikins (which were thereafter coded with a maximum of 35 marked sites 
(Figure 1)).  They were also asked whether the pain had lasted at least three months (indicating 
chronic pain).  Manikin coding was conducted within each study by trained research staff.  This 
procedure has previously shown high interrater reliability in the classification of widespread pain [8]. 
The Epidemiology of Functional Disorders (EpiFund) is a prospective cohort study, consisting of a 
random sample of 25-65 year-olds from three areas of the UK [9].  Data from the initial recruitment 
survey, collected by means of self-complete postal questionnaire, was used for the current analysis.  
Information was collected on sleep problems (Estimation of sleep problem scale [10]), mood 
symptoms (Hospital anxiety & depression scales [11]) and the presence of somatic symptoms 
(Somatic symptom scale [12]).  
 
The Kid Low Back Pain (Kid LBP) study is a prospective cohort study conducted across secondary 
schools in Cheshire and North Derbyshire, UK [13].  School children, aged between 11 and 14 years 
were eligible for the study.  Data from the initial self-complete questionnaire was used for the 
current analysis. 
 
The Managing Unexplained Symptoms (Chronic Widespread Pain) in Primary Care: Involving 
Traditional and Accessible New Approaches (MUSICIAN) study is a 2x2 factorial randomised 
controlled trial, undertaken to investigate the management of chronic widespread pain (CWP) [14].  
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GP practices across Aberdeen City and the North Cheshire County of the UK were used as a sampling 
frame, from which randomly selected individuals aged 25 years or above were sent a self-complete 
screening questionnaire by post, data from which is used in the current analysis.  
 
The Study of Health and its Management (SHAMA) is a cross-sectional study of individuals, residing 
in the Grampian region of the UK, aged 25 years or over [15] who self-completed a questionnaire 
sent by post.  The questionnaire included a measurement of quality of life (Short form 36 [16]). 
  
The National Child Development (1958 British birth cohort) study included all children born in Great 
Britain over a period of time in March 1958.  Subjects have been followed up over the course of their 
lifetime [17].  In 2003 (when the cohort was 45 years old), participants self-completed a 
questionnaire which included a measure of psychological distress (General health questionnaire 
[18]).  
 
The Women’s Health Study (WHEST) is a cross-sectional study of females, aged 25 years or above, 
resident in the Grampian region of the UK who were sent a self-complete questionnaire by post.  
This questionnaire included measures of fatigue (Chalder fatigue scale [19]), sleep disturbance 
(Estimation of sleep problem scale [10]), somatic symptom reporting (Somatic symptom scale [12]) 
and depression (Patient health questionnaire–9 [20]). 
 
Consent was obtained from potential participants within each original study as per their individual 
governance arrangements.  All data used within the current study were fully anonymised.  
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Classification of pain: 
Participants were classified as having widespread pain (contralateral pain and pain in the axial 
skeleton) and chronic widespread pain (widespread pain lasting ≥3 months), regional pain (pain 
which was not widespread) or no pain [1]. 
 
The cumulative distribution of the number of painful body sites was examined within each of the six 
study populations and was used to determine definitions of multi-site pain (MSP) which produced 
the closest prevalence to that of chronic widespread pain (according to the ACR 1990 definition).  As 
an example; if X% of the study population reported CWP (ACR 1990); we chose the number of sites 
whose cumulative distribution was closest to 100-X% as the definition of ‘MSP’.  This process was 
conducted twice, once to include all body locations, hereafter defined as ‘MSP (+joints)’, and 
secondly with the exclusion of all 10 joint areas, hereafter defined as ‘MSP (-joints)’. 
 
Statistical analysis 
The characteristics of each of the populations, and the subgroups fulfilling the CWP, MSP +joints, 
and MSP -joints definitions, were examined using simple descriptive statistics: reported as 
proportions for categorical variables and population mean (standard deviation) for continuous 
factors.   
 
The relationship between the additional symptoms associated with fibromyalgia and the reporting of 
each of these pain definitions, were assessed using multiple binary logistic regression models.  
Fatigue was assessed using the Chalder fatigue scale, categorised by standard cut-offs into: none 
(score 0), mild (scores 1-3) and moderate/severe (scores 4-11) [19] or the short form 36 vitality 
score.  Due to the skewed distribution of the data a pragmatic approach was chosen to categorise 
the short form vitality into three tertiles; highest tertile (scores 81-100), mid tertile (scores 58-80) 
and poorest tertile (scores 0-57) [16].  All analyses were thereafter conducted comparing the 
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poorest tertile to the middle and highest combined in order to maximise patient N while also 
retaining a clinically meaningful group.  Sleep problems were assessed using the Estimation of sleep 
problem scale, categorised by standard cut-offs as no sleep problems (scores 0 -11) or sleep 
problems (scores 12- 20) [10] and the presence of any somatic symptoms by the Somatic symptom 
scale [12].  Lastly, emotional/mental health was assessed by four different instruments.  The General 
health questionnaire (GHQ) was subdivided into tertiles (highest tertile (score 0), mid tertile (scores 
1-2) and poorest tertile (scores 3-12) [18]).  The Patient health questionnaire was subdivided into 
mild, moderate, moderately/severe and severe according to standard instrument cut-offs [21].  The 
Short form 36 mental health score was divided into tertiles due to skewed distribution (highest 
tertile (score 0-79) mid tertile (scores 80-86) and poorest tertile (scores 87-100) [16]) and analysis 
conducted on the poorest vs. the moderate and high groups.  Lastly the Hospital anxiety and 
depression scales (HADS) were group into: no, borderline and clinical anxiety/depression according 
to standard instrument cut-offs [11]. 
 
Additionally, to assess potential sexual dimorphism; of those reporting MSP +joints, differences in 
the reporting of the additional symptoms associated with fibromyalgia were assessed, stratified by 
gender.  For all logistic regression models, results are presented as odds ratios (OR) and 95% 
confidence intervals (CI).   
 
All statistical analysis was undertaken using STATA (StataCorp LP version 13).  
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RESULTS 
 
Characteristics of study populations  
The total number of participants was 34,818 and from each study varied from 1,440 (Kid LBP) to 
14,680 (MUSICIAN).  Excluding WHEST, which contained only females, the proportion of male 
participants ranged between 43% and 51% (Table 1).  The mean age range within the adult cohorts 
was narrow; 42 - 56 years, while children in the Kid LBP study had a mean age of 12 years.  The 
prevalence of CWP within the adult studies varied between 12 and 17% and was lower within the 
only child population (7%) (Table 1). 
 
Multi-site pain definition: 
Although the prevalence of CWP differed between the adult study populations, the number of 
corresponding sites defining both MSP +joints and MSP -joints definitions was consistent across all; 
namely eight sites and above (Table 2).  Only within the child population, the corresponding MSP (+ 
and - joints) definitions were different; at least 10 sites. 
 
There was substantial overlap between CWP and MSP groups (Table 2).  Within the adult 
populations, of persons satisfying the definition of MSP +joints, between 62 and 72% also fulfilled 
the CWP definition.  Amongst those meeting the MSP -joints definition, between 68 and 79% also 
met the definition of CWP.  Amongst the child population, those also fulfilling the CWP definition 
were substantially lower (39% and 42% respectively).  There was consistency in the mean age and 
gender proportions across the adult population groups (Table 3).  For example, within the EpiFunD 
study, the mean age in both CWP and MSP +joints groups was 48 years (standard deviation (sd) 11) 
and in the MSP -joints groups was 47yrs (sd11).  The proportion male in the same study was 36%, 
35% and 30%, for CWP, MSP +joints, and MSP -joints groups, respectively. 
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Relationship between pain and the additional symptoms associated with fibromyalgia 
The populations meeting the CWP, MSP +joints and MSP -joints criteria, were characterised by their 
reporting of fatigue, sleep problems, somatic symptoms and mental/emotional health. 
 
Fatigue 
Fatigue was assessed within two studies (SHAMA and WHEST).  Those who reported fatigue were 
more likely to report pain, regardless of pain definition used (Table 4).  The magnitude of this 
association was greater with multi-site pain definitions.  For example, within the WHEST study; 
compared to no fatigue, reporting moderate/severe fatigue was associated with a 5-fold increase in 
the odds of CWP (OR 5.2, 95% confidence interval 3.9-6.9) and a 6.5-fold increase in the odds of MSP 
(MSP +joints 6.5, 5.0-8.6; MSP -joints 6.5, 4.7-9.0) (Table 4).   
 
Sleep Problems 
Sleep problems were assessed within two studies (WHEST and EpiFunD).  Those who reported sleep 
problems had a 4-fold increased odds of reporting pain (Table 4) and this was consistent across pain 
definition.  For example, within the EpiFunD study: CWP 4.1, 3.6-4.8, MSP +joints 4.1, 3.6-4.8, MSP -
joints 4.2, 3.5-5.0 (Table 4). 
 
Somatic Symptoms  
Somatic symptoms were assessed within two studies (WHEST and EpiFunD).  The reporting of any 
somatic symptom was associated with an increased odds of reporting pain.  The magnitude of this 
association was similar across all pain definitions for each individual symptom.  For example, within 
the EpiFund study, reporting breathing difficulties was associated with around a 2.5-fold increase in 
the odds of reporting pain: CWP 2.5, 2.1-2.8, MSP +joints 2.6, 2.3-2.98, MSP -joints 2.7, 2.3-3.3 
(Table 4).  The only notable difference in pain reporting was demonstrated within the somatic 
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symptom of digit pain, in which the odds of pain reporting was larger for MSP +joints compared to 
the other pain groups:  CWP 4.2, 3.7-4.9, MSP +joints 5.2, 4.5-5.9, MSP -joints 4.6, 3.9-5.5 (Table 4). 
 
Mental and Emotional Health 
Mental/emotional health was assessed within four studies (1958 British birth cohort, WHEST, 
SHAMA and EpiFunD).  Generally, reporting impaired mental health was associated with an 
increased odds of reporting pain (Table 4).  The magnitude of this association increased as the 
severity of mental health problems worsened but was consistent across pain definitions.  As an 
example, within the EpiFunD study and using the HADS scale; reporting borderline depression was 
associated with at least a 2.5-fold increase in the odds of pain (CWP 2.5, 2.1-3.1, MSP +joints 2.5, 
2.0-2.99, MSP -joints 2.9, 2.3-3.7) while reporting clinical depression was associated with over a 4-
fold increase in this (CWP 4.5, 3.6-5.5, MSP +joints 4.2, 3.4-5.2, MSP -joints 4.7, 3.7-6.0) (Table 4). 
 
Relationship between pain and the additional symptoms associated with fibromyalgia, stratified 
by gender 
With the aim of assessing potential sexual dimorphism, stratification was used to assess gender 
differences in the association between pain reporting (MSP +joints) and other additional symptoms 
associated with fibromyalgia. 
 
Reporting fatigue was associated with an increased odds of reporting pain regardless of gender 
(Table 5).  Amongst females, compared to those reporting moderate/high vitality (SF-36 vt score 58-
100): those reporting poor vitality (score 0-57) had a 5-fold increase in the odds of also reporting 
MSP +joints (5.1, 3.3-7.7).  Within males, the odds of pain reporting in the presence of poor vitality 
was 4.4, 2.7-7.1.  Those who reported sleep problems demonstrated an increased odds of reporting 
MSP +joints, and the magnitude of this association was similar across both males and females: 4.4, 
3.5-5.6 (males), 3.8, 3.2-4.6 (females) (Table 5).  Additionally, those reporting somatic symptoms 
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were more likely to report MSP +joints (Table 5) and the magnitude of this was similar across 
gender.  For example, reporting breathing difficulties was associated with around a 2.5-fold increase 
in the odds of pain in both males (2.4, 1.9-3.1) and females (2.6, 2.2-3.1).  Lastly, those who reported 
impaired mental health were more likely to report MSP +joints regardless of gender (Table 5).  For 
example, reporting borderline depression (compared to no depression) was associated with over a 
doubling in the odds of pain (males: 2.9, 2.1-4.1, females: 2.3, 1.8-2.9) and reporting clinical 
depression was associated with over a quadrupling in the odds of this (males: 5.0, 3.6-6.7, females: 
4.2, 3.2-5.5). 
 
In addition to the raw comparison of the relationship between pain and the additional associated 
symptoms  of fibromyalgia by gender, potential differences were further assessed using interaction 
terms.  These additional models (data not shown) confirmed that there were no statistically 
significant interactions between gender and fatigue, sleep problems, somatic symptoms or 
mental/emotional health (p values all >0.05). 
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DISCUSSION 
 
The aims of this study were to assess and compare the descriptive epidemiology of pain area 
reporting using widespread and multi-site definitions and to determine if the relationship between 
these definitions and the other symptoms associated with fibromyalgia differ.  We have 
demonstrated that there is little difference - the magnitude of association was similar between 
fatigue, sleep disturbance, the reporting of somatic symptoms or cognitive problem and CWP or 
MSP (with or without consideration of joint pain).  Additionally, there is no indication of systematic 
differences in the magnitude of these associations by gender. 
 
There are a number of methodological considerations in interpreting the current findings.  Firstly, 
one of the primary aims of the study was to assess the relationship between alternative pain area 
definitions (CWP/MSP) and the additional associated symptoms of fibromyalgia.  The MSP definition 
was formulated in such a way as to identify a population which gave a similar prevalence to that of 
CWP.  Due to this, one may expect that a) both groups would include many of the same individuals 
and b) therefore the study would have only modest power to detect potential differences.  The 
overlap observed was between 60 and 76%, leaving a substantial number of unique individuals 
within each group.  Additionally, the characteristics of those within the groups differed – pain 
chronicity being the most apparent.  By definition, 100% of the CWP group experienced chronic pain 
(pain ≥ 3 months duration), however within the MSP groups this dropped to as low as 77% (adult 
population).  The similarities shown between groups are therefore not solely due to the overlap of 
patients, although this will have contributed.  
 
The relationship between pain and the other associated symptoms of FM was assessed through 
bivariate analysis using studies which contained both a measure of pain (which allowed the 
classification of CWP and MSP) and at least one of the associated symptoms FM features.  
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Unfortunately no single study contained all predictors, therefore a fully adjusted model could not be 
created.  Although the aim here was to deduce how these features individually predicted pain; 
future studies assessing whether these relationships remain when controlling for the other 
symptoms would be valuable.   
 
Additionally, although the magnitude of association between these symptoms and pain were 
broadly similar across pain definition, there were differences noted across the study and measure 
used.  Although there was little overlap in the instruments across studies, both WHEST and EpiFunD 
collected identical sleep disturbance and somatic symptom measures.  The results from these 
studies exhibited small differences in the magnitude of association with pain; differences which may 
largely be due to the study populations themselves.  While EpiFunD is a general population survey, 
WHEST only recruited females, and as females are generally more likely to report symptoms such as 
insomnia and sleep disturbance [22], these differences are perhaps not surprising.  Conversely, 
multiple instruments were used to measure both fatigue and emotional/mental health.  Although 
differences in the magnitude of association with pain can partly be attributed to the fact that 
different instruments, although broadly measure similar concepts, are not identical and may be 
expected to be capturing slightly different aspects.  It should be noted that although there were 
differences in OR across measures, all multiple level outcomes demonstrated similar dose-
relationship trends – e.g. the worse the mental/emotional category the greater the likelihood of 
reporting pain.  
  
Within the current study four-view body manikins were used to assess pain areas rather than those 
presented within the published fibromyalgia criteria [1, 4, 5].  As the 2011 modification, for use 
within epidemiological and clinical studies, is a relatively recent development, none of the 
population studies used within the current analysis included this.  Pain areas were assessed, through 
the pain manikins present across all six studies.  It is interesting to note that despite the use of a 
Page 16 of 26
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
different pain area definition, ultimately the number of pain sites needed (≥ 8) to define MSP within 
the adult studies was very similar and is consistent to those proposed within other studies [23].  
 
This large scale post hoc study, encompassing over 34,000 individuals across multiple studies, is the 
first to assess the association between different pain area definitions and the relationship with the 
other symptoms associated with fibromyalgia and demonstrated similar magnitudes of association 
regardless of the definition used.  In the absence of ‘gold standard’ criteria for fibromyalgia, we have 
shown that there may be multiple ways in which the core feature of this syndrome, namely pain, 
could be defined - a concept which has been demonstrated in other conditions, such as within the 
classification of shoulder pain [24].  Although CWP has been the underpinning concept of the ACR 
1990 classification of fibromyalgia, its prevalence differs considerably based on the specific 
definition used [25].  In line with previous studies which sought to compare associations of 
widespread and multi-site pain with known risk factors, the current study supports classification of 
pain simply by number of sites [26, 27]. 
 
The original ACR 1990 classification criteria included a definition of pain distribution which is 
widespread and included joint areas [1], however the more recent 2010/2011 modifications have 
gone on to classify multi-site pain without considering many of the original joint areas [4, 5].  Within 
the current study we aimed to determine if the re-inclusion of joints within a MSP definition would 
result in differences in the relationship with the additional features of fibromyalgia.  The results 
presented have shown, in fact, that there is little difference in the relationship between pain and the 
other features regardless as to whether joint areas were included or not.  Excluding these areas from 
classification criteria may omit a large proportion of individuals who exhibit pain in multiple sites but 
due to the specific location of these do not meet the current widespread definition [4, 5].  Future 
classification criteria for fibromyalgia may consider the re-inclusion of joint areas within the 
definition of pain.. 
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 The current study also aimed to determine, amongst those fulfilling the new definition of MSP, 
whether there were gender differences in the reporting of the other features of fibromyalgia.  
Although fibromyalgia is more common in females (particularly when 1990 or clinical diagnoses are 
used [6]), the current study did not provide evidence of differences in the relationship between pain 
and these features.  This is consistent with previous studies which have shown that there is little 
difference by gender in the reporting of symptoms such as anxiety/depression [28, 29, 30] and 
somatic symptoms [29] amongst those reporting pain.  
 
Lastly, in addition to including several independent adult populations, the current study also 
included a study in schoolchildren (Kid LBP study).  Within the juvenile population, the prevalence of 
CWP was lower than within adults, however regional pain was more common.  This may be 
explained, in part, by the developmental stage of the study participants and indicates that standard 
‘adult’ definitions of pain may not be suitable for child populations.  Furthermore, the classification 
of widespread and multi-site pain may need to be made differently in this group.  This is supported 
by previous studies which indicated differences in the reporting of FM symptoms in young adults 
[31].  Specifically that the additional features of FM (notably sleep quality and depressive symptoms) 
demonstrated stronger association with symptom severity than for widespread pain. 
 
To our knowledge, this is the largest study (utilizing information on over 34,000 individuals across 
multiple studies) to have assessed the association between pain areas and the other associated 
symptoms of fibromyalgia in the context of alternative pain definitions.  We have demonstrated 
similar magnitudes of association with chronic widespread and multi-site pain (whether or not joint 
areas are included).  Although the results presented here should be further validated within other 
populations outside the United Kingdom, researchers and clinicians alike should be advised that the 
continued collection of information on the additional associated symptoms of fibromyalgia, in 
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conjunction to pain, remain important when classifying fibromyalgia but that this pain definition may 
not necessarily require to follow those outlined by the 1990 ACR criteria for fibromyalgia.  
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Figure 1 - 4-View Body Manikins with scoring 
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 Table 1 - Characteristics of those in the included studies, who answered pain question 
 SHAMA WHEST EpiFund MUSICIAN Kid LBP 1958 BBC 
N. 1,579 2,303 6,244 14,680 1,440 8,572 
% male 45% 0% 43% 43% 46% 51% 
Age (mean, SD) years 55 (15) 53 (15) 46 (11) 56 (16) 12 (0.9) 42 (-) 
Type of pain (n (%)) 
No  782 (50) 1,028 (45) 2,343 (38) 5,424 (37) 390 (27) 4,019 (47) 
Regional 570 (36) 884 (38) 2,709 (43) 6,601 (45) 863 (60) 3,318 (39) 
Widespread 30 (2) 54 (2) 129 (2) 239 (2) 109 (8) 179 (2) 
Chronic Widespread 197 (12) 337 (15) 1,603 (17) 2,416 (16) 78 (7) 1,056 (12) 
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 Table 2 - New multi-site definitions and comparisons with CWP definition 
 SHAMA WHEST EpiFund MUSICIAN Kid LBP 1958 BBC 
MSP definition  + 
joints 
-  
joints 
+ 
joints 
-  
joints 
+  
joints 
-  
joints 
+  
joints 
-  
joints 
+ 
 joints 
-  
joints 
+  
joints 
-  
joints 
No of sites for definition ≥8  ≥8 ≥8 ≥8 ≥8 ≥8 ≥8 ≥8 ≥10 ≥10 ≥8 ≥8 
N. of those fulfilling MSP 219 136 397 235 1,061 568 2,715 1,623 84 26 1,110 633 
% who also had CWP* 62% 68% 66% 75% 72% 75% 68% 79% 39% 42% 66% 74% 
*Chronic Widespread Pain defined according to the ACR 1990 criteria 
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Table 3 - Characteristics of pain populations 
 SHAMA WHEST EpiFund MUSICIAN KidsLBP 1958birth 
CWP MSP  
+ 
joints 
MSP 
- 
joints 
CWP MSP  
+ 
joints 
MSP 
- 
joints 
CWP MSP  
+ 
joints 
MSP 
- 
joints 
CWP MSP  
+ 
joints 
MSP 
- 
joints 
CWP MSP  
+ 
joints 
MSP 
- 
joints 
CWP MSP  
+ 
joints 
MSP 
- 
joints 
% male 37% 37% 35% - - - 36% 35% 30% 36% 37% 36% 45% 46% 58% 47% 47% 48% 
Mean age  
 (SD) 
56  
(12) 
54  
(14) 
53 
(14) 
54 
(15) 
53 
(15) 
45 
(13) 
48 
(11) 
48 
(11) 
47 
(11) 
57 
(15) 
57 
(15) 
56 
(16) 
13  
(1) 
13  
(1) 
13  
(1) 
- - - 
Pain chronicity  
(>3 months) 
100% 89% 88% 100% 77% 95% 100% 93% 93% 100% 93% 92% 100% 45% 42% 100% 89% 89% 
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Table 4 – Relationship between MSP/CWP and symptoms associated with fibromyalgia 
Measure [population] CWP MSP + joints MSP - joints 
 N.* OR 95% CI N.* OR 95% CI N.* OR 95% CI 
Fatigue 
SF-36 Vitality (vs. Med/High tertile – score 58-100) [SHAMA] 
Poor (score 0-57) 1579 5.3 3.8-7.5 b 1579 4.9 3.5-6.7 b 1579 5.1 3.4-7.6 b 
Chalder Fatigue Scale (vs. absent) [WHEST] 
Mild (score 1-3) 
2178 
2.9 2.1-3.9 b 
2178 
3.0 2.2-4.0 b 
2178 
3.0 2.1-4.3 b 
Mod/Severe (score 4-11) 5.2 3.9-6.9 b 6.5 5.0-8.6 b 6.5 4.7-9.0 b 
Sleep Problems 
Estimation of sleep problems (vs. no) [WHEST] 
Yes 2258 3.6 2.9-4.7 b 2258 3.8 3.0-4.7 b 2258 4.3 3.3-5.7 b 
Estimation of sleep problems (vs. no) [EpiFunD] 
Yes 6039 4.1 3.6-4.8 b 6027 4.1 3.6-4.8 b 6039 4.2 3.5-5.0 
Somatic Symptoms Present 
Somatic Symptom Scale (yes vs no) [WHEST] 
Breathing difficulties 2291 2.7 2.1-3.4 b 2291 3.1 2.5-3.9 b 1195 2.0 1.5-2.6 b 
Menstrual cramps 2276 2.4 1.9-3.1 b 2276 2.3 1.8-2.8 b 1187 2.1 1.6-2.8 b 
Lost voice 2290 1.3 1.0-1.8 2290 1.6 1.2-2.1 b 1195 1.1 0.8-1.7 
Difficulty swallowing 2298 2.9 2.2-3.7 b 2298 3.0 2.3-3.8 b 1200 1.9 1.4-2.6 b 
Memory loss 2293 2.9 2.2-4.0 b 2293 3.4 2.5-4.5 b 1194 2.6 1.8-3.6 b 
Frequently vomit 2294 2.4 1.6-3.6 b 2294 2.5 1.7-3.7 b 1197 1.9 1.2-3.0
a 
Digit pain 2289 4.8 3.7-6.2 b 2289 5.7 4.4-7.2 b 1192 2.3 1.7-3.1 b 
Somatic Symptom Scale (yes vs no) [EpiFund] 
Breathing difficulties 6196 2.5 2.1-2.8 b 6210 2.6 2.3-3.0 b 6210 2.7 2.3-3.3 b 
Menstrual cramps 3426 1.7 1.4-2.0 b 3432 1.7 1.4-2.0 b 3432 1.8 1.5-2.3 b 
Lost voice 6214 1.5 1.3-1.8 b 6228 1.4 1.2-1.7 b 6228 1.5 1.2-1.8
a 
Difficulty swallowing 5326 2.7 2.3-3.2 b 5338 2.7 2.3-3.2 b 5338 2.6 2.1-3.2 b 
Memory loss 6208 2.5 2.1-3.0 b 6221 2.4 2.0-2.9 b 6221 2.4 1.9-3.0 b 
Frequently vomit 6185 2.8 2.2-3.7 b 6198 2.8 2.1-3.7 b 6198 3.4 2.5-4.7 b 
Digit pain 6187 4.2 3.7-4.9 b 6201 5.2 4.5-5.9 b 6201 4.6 3.9-5.5 b 
Emotional/Mental Health 
General Health Questionnaire (vs. top tertile – score 0) [1958 British birth cohort] 
Mid (score 1-2) 
8283 
1.5 1.3-1.8 b 
8283 
1.3 1.1-1.5
a 
8283 
1.3 1.1-1.7 b 
Poor (score 3-12) 2.3 1.9-2.7 b 2.2 1.9-2.6 b 2.5 2.1-3.1 b 
Patient Health Questionnaire - 9 (vs. no depression) [WHEST] 
Mild depr. 
2215 
3.4 2.6-4.5 b 
2215 
3.3 2.5-4.5 b 
1145 
2.1 1.5-3.1 b 
Moderate depr. 7.1 5.0-10.1 b 5.7 3.9-8.2 b 4.1 2.7-6.4 b 
Moderately severe depr. 10.5 6.4-17.3 b 10.5 6.4-17.4 b 7.9 4.3-14.3 b 
Severe depr. 11.2 6.0-21.1 b 9.1 4.8-17.3 b 7.9 3.6-17.2 b 
SF-36 Mental Health (vs. Med/High tertile – score 80-100) [SHAMA] 
Poor (score 0-79) 1578 2.9 2.1-3.9 b 1578 3.3 2.4-4.5 b 1578 3.2 2.2-4.7 b 
Hospital Anxiety and Depression Scale (vs. none (score 0-7)) [EpiFund] 
Anx. Borderline (score 8-10) 
6161 
1.9 1.6-2.3 b 
6148 
1.8 1.5-2.1 b 
6161 
2.1 1.7-2.7 b 
 Present (score 11-21) 3.2 2.7-3.7 b 3.2 2.7-3.8 b 3.3 2.7-3.7 b 
Depr. Borderline (score 8-10) 
6169 
2.5 2.1-3.1 b 
6155 
2.5 2.0-3.0 b 
6169 
2.9 2.3-3.7 b 
 Present (score 11-21) 4.5 3.6-5.5 b 4.2 3.4-5.2 b 4.7 3.7-6.0 b 
OR – Odds Ratio   
* Model N. 
 
 
95% CI – 95% Confidence Interval  
a
 p<0.05  
b
 p<0.001 
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 Table 5 – Relationship between MSP (+ joints) and symptoms associated with fibromyalgia, stratified by 
gender 
Measure [population] Males Females 
 N.* OR 95% CI N.* OR 95% CI 
Fatigue 
SF-36 Vitality (vs. Med/High tertile – score 58-100) [SHAMA] 
Poor (score 0-57) 705 4.4 2.7-7.1
b
 874 5.1 3.3-7.7
 b
 
Sleep Problems 
Estimation of sleep problems (vs. no) [EpiFunD] 
Yes 2631 4.4 3.5-5.6
 b
 3408 3.8 3.2-4.6
 b
 
Somatic Symptoms 
Somatic Symptom Scale (yes vs no) [EpiFund] 
Breathing difficulties 2706 2.4 1.9-3.1
 b
 3504 2.6 2.2-3.1
 b
 
Menstrual cramps  - - 3400 1.7 1.4-2.0
 b
 
Lost voice 2709 1.2 0.8-1.7 3519 1.3 1.1-1.6
a 
Difficulty swallowing 2360 2.9 2.2-3.9
 b
 2975 2.5 2.0-3.1
 b
 
Memory loss 2704 2.7 2.0-3.6
 b
 3517 2.3 1.8-2.9
 b
 
Frequently vomit 2686 2.8 1.7-4.6
 b
 3512 2.7 1.9-3.7
 b
 
Digit pain 2699 4.8 3.9-6.1
 b
 3502 5.2 4.4-6.3
 b
 
Emotional/Mental Health 
General Health Questionnaire (vs. top tertile – score 0) [1958 British birth cohort] 
Mid (score 1-2) 
4046 
1.1 0.9-1.4 
4237 
1.5 1.2-1.9
 b
 
Poor (score 3-12) 1.9 1.5-2.4
 b
 2.5 2.0-3.1
 b
 
SF-36 Mental Health (vs. Med/High tertile – score 80-100) [SHAMA] 
Poor (score 0-79) 705 3.3 2.0-5.3
 b
 873 3.2 2.2-4.7
 b
 
Hospital Anxiety and Depression Scale (vs. none (score 0-7)) [EpiFund] 
Anxiety Borderline (score 8-10) 
2685 
2.3 1.7-3.0
 b
 
3476 
1.6 1.3-2.0
 b
 
 Present (score 11-21) 3.8 2.9-5.0
 b
 2.7 2.2-3.3
 b
 
Depression Borderline (score 8-10) 
2681 
2.9 2.1-4.1
 b
 
3488 
2.3 1.8-2.9
 b
 
 Present (score 11-21) 5.0 3.6-7.0
 b
 4.2 3.2-5.5
 b
 
OR – Odds Ratio   
a
 p<0.05 
* Model N. 
 
 
 
 95% CI – 95% Confidence Interval 
b
 p<0.001 
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